Fragment-to-Lead Medicinal Chemistry Publications in 2019
Jahnke, Wolfgang, Erlanson, Daniel A, de Esch, Iwan JP, Johnson, Christopher N, Mortenson, Paul N, Ochi, Yuji and Urushima, Tatsuya (2020) Fragment-to-Lead Medicinal Chemistry Publications in 2019. Journal of Medicinal Chemistry, 63 (24). pp. 15494-15507. ISSN 15204804
Abstract
Fragment-based drug discovery (FBDD) has grown and matured to a point where it is valuable to keep track of its extent and details of application. This Perspective summarizes successful fragment-to-lead stories published in 2019. It is the fifth in a series that started with literature published in 2015. The analysis of screening methods, optimization strategies, and molecular properties of hits and leads are presented in the hope of informing best practices for FBDD. Moreover, FBDD is constantly evolving, and the latest technologies and emerging trends are summarized. These include covalent FBDD, FBDD for the stabilization of proteins or protein-protein interactions, FBDD for enzyme activators, new screening technologies, and advances in library design and chemical synthesis.
Item Type: | Article |
---|---|
Date Deposited: | 20 Apr 2021 00:45 |
Last Modified: | 20 Apr 2021 00:45 |
URI: | https://oak.novartis.com/id/eprint/43343 |